Opendata, web and dolomites

SURE SIGNED

3-D Super resolution Ultrasound Real time imaging of Erythrocytes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SURE project word cloud

Explore the words cloud of the SURE project. It provides you a very rough idea of what is the project "SURE" about.

gbytes    volume    ultrasound    frame    injection    data    hz    effort    detecting    silicon    diabetes    resolving    volumes    column    cancer    tracks    400    estimation    coded    breakthroughs    screening    quantification    faster    synthetic    groups    motion    full    pressure    possibility    individual    visualization    cm    combing    goals    shift    diagnostic    erythrocytes    hundreds    visualizing    rates    human    agents    deep    super    red    tracking    repeated    diagnoses    million    imaging    dimensional    resolution    paradigm    anatomy    gradient    sure    body    adverse    newborns    treatment    blood    normal    attained    rodents    scientific    times    micrometer    clinical    population    2600    aperture    contrast    cells    perfusion    directions    row    thereby    volumetric    humans    yield    diagnosis    leads    13    flow    time    disease    learning    ultrafast    vascular    capillary    elderly    performed    isotropic    synergistic    trials    levels    probes   

Project "SURE" data sheet

The following table provides information about the project.

Coordinator
DANMARKS TEKNISKE UNIVERSITET 

Organization address
address: ANKER ENGELUNDSVEJ 1 BYGNING 101 A
city: KGS LYNGBY
postcode: 2800
website: www.dtu.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 9˙980˙899 €
 EC max contribution 9˙980˙899 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-SyG
 Funding Scheme ERC-SyG
 Starting year 2020
 Duration (year-month-day) from 2020-03-01   to  2026-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) coordinator 7˙384˙019.00
2    REGION HOVEDSTADEN DK (HILLEROD) participant 1˙431˙565.00
3    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) participant 1˙165˙315.00

Map

 Project objective

'The SURE project: 'Super resolution Ultrasound Real time imaging of Erythrocytes' will develop and research a new super resolution ultrasound imaging method capable of resolving capillary flow in the human body. The approach tracks the motion of the individual red blood cells (erythrocytes) in a three-dimensional volume for a full visualization of anatomy, flow, and perfusion in a volume down to 13 cm at 20 volumes per second. The super resolution imaging is performed without using contrast agents and is thereby 2600 times faster than current methods. The method has an isotropic resolution of 50 micrometer in all directions, and the volumetric resolution is thereby 100-400 times better than current state-of-the-art 3-D ultrasound imaging. These highly ambitious goals are attained in a synergistic research effort combing four research groups. The scientific project includes breakthroughs in silicon row-column probes with 1 million elements, advanced synthetic aperture ultrafast coded imaging, deep learning for detecting and tracking of cells, pressure gradient estimation, and visualization and quantification of several hundreds of Gbytes volumetric data. The research finally leads to clinical trials conducted on rodents and humans for studying the changes in perfusion for diabetes and cancer. The SURE imaging approach can yield a paradigm shift in the scientific study, diagnoses, and treatment of cancer, diabetes, and vascular disease at the capillary level, as it enables the possibility of volumetric visualizing capillary perfusion in real-time at frame rates above 20 Hz without injection of contrast agents. Imaging is performed using ultrasound at normal diagnostic levels with no known adverse effects and can, thus, be used on a wide range of the population from newborns to the elderly for both diagnosis and repeated screening.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SURE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SURE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

evolSingleCellGRN (2019)

Constraint, Adaptation, and Heterogeneity: Genomic and single-cell approaches to understanding the evolution of developmental gene regulatory networks

Read More  

IMMUNOTHROMBOSIS (2019)

Cross-talk between platelets and immunity - implications for host homeostasis and defense

Read More  

RODRESET (2019)

Development of novel optogenetic approaches for improving vision in macular degeneration

Read More